Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
The Sydney AIDS Project. Sydney AIDS study group.
Med J Aust. 1984 Oct 27;141(9):569-73. Unique Identifier : AIDSLINE MED/85036005
Abstract:
The frequency of specific clinical, epidemiological, and immunological characteristics associated with the possible development of AIDS was established in a cohort of homosexual men living in metropolitan Sydney. During a six-month period, 289 subjects were enrolled into a prospective study. The initial findings in this cohort indicate that almost one-third of subjects led a fast-lane lifestyle, 28% had lymphadenopathy, and 27% had T4:T8 ratios below 0.9 - features which are risk factors associated with the development of AIDS and related disorders. Subjects will be examined every six months for at least two years to determine the relationship between lifestyle characteristics and changes in the results of immunological and antibody status tests for human T-cell lymphotropic virus (HTLV). The study population should not be considered representative of the homosexual population of Sydney, but the high prevalence of risk factors among the cohort gives cause for concern that AIDS may become a widespread public health problem in this community. The results of this study will assist in defining the natural history of AIDS in a population in which the incidence of disease is still relatively low.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/IMMUNOLOGY/ TRANSMISSION Adult Antibodies, Monoclonal/ANALYSIS Australia Disease Outbreaks/*EPIDEMIOLOGY Fever of Unknown Origin/ETIOLOGY Homosexuality Human HTLV-BLV Viruses/IMMUNOLOGY Leukocyte Count Life Style Male Pilot Projects Prospective Studies Retroviridae Infections/COMPLICATIONS Risk Support, Non-U.S. Gov't T-Lymphocytes/IMMUNOLOGY JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
